| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 12/08/2010 | CN101910150A 4-benzylamino-1-carboxyacyl-piperidine derivatives as CETP inhibitors useful for the treatment of diseases such as hyperlipidemia or arteriosclerosis |
| 12/08/2010 | CN101910145A Heterocyclic antiviral compounds |
| 12/08/2010 | CN101910143A Condensed aminodihydrothiazine derivative |
| 12/08/2010 | CN101910142A Modulators for amyloid beta |
| 12/08/2010 | CN101910141A A novel alpha-(N-sulfonamido)acetamide compound as an inhibitor of beta amyloid peptide production |
| 12/08/2010 | CN101910137A 1,3-dialkyl-benzimidazole halogenides exhibiting regeneration, anti-inflammatory and antimicrobial activity |
| 12/08/2010 | CN101910133A Heterocycle phenyl amide T-type calcium channel antagonists |
| 12/08/2010 | CN101910132A Novel piperidine-4-carboxylic acid phenyl-alkyl-amide derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 12/08/2010 | CN101910131A Carboxamide, sulfonamide and amine compounds for metabolic disorders |
| 12/08/2010 | CN101910128A Novel diazeniumdiolate derivatives, method for the preparation thereof and pharmaceutical compositions containing the same |
| 12/08/2010 | CN101910127A (aza)indole derivative substituted in position 5, pharmaceutical composition comprising it, intermediate compounds and preparation process therefor |
| 12/08/2010 | CN101910126A Proline analogs as ligands for cannabinoid receptors for the treatment of pain |
| 12/08/2010 | CN101910125A Compounds from mycelium of antrodia cinnamomea and use thereof |
| 12/08/2010 | CN101910121A Bis-(sulfonylamino) derivatives in therapy 066 |
| 12/08/2010 | CN101910111A Processes for preparing a substituted gamma-amino acid |
| 12/08/2010 | CN101909693A Combination of anti-CTLA4 antibody with tubulin modulating agents for the treatment of proliferative diseases |
| 12/08/2010 | CN101909655A Method of delivering an anti-cancer agent to a cell |
| 12/08/2010 | CN101909653A Composition exhibiting high osmotic antimicrobial, anti-inflammatory and regeneration activity |
| 12/08/2010 | CN101909651A External preparation composition comprising fatty acid-based ionic liquid as active ingredient |
| 12/08/2010 | CN101909645A Blood pressure lowering combination comprising IPP and/or VPP |
| 12/08/2010 | CN101909644A Prevention of opportunistic infections in immune-compromised subjects |
| 12/08/2010 | CN101909640A Composition for improving nutritional status, reducing frequency of fever and/or increasing immunocompetence of elderly |
| 12/08/2010 | CN101909639A Composition for reducing oxidative stress and/or side effects occurring during cancer chemotherapy or improving nutritional status during cancer chemotherapy |
| 12/08/2010 | CN101909637A Method of determining the probability of a therapeutic response in cancer chemotherapy with cardiac glycoside |
| 12/08/2010 | CN101909636A Use of oligosaccharides containing N-acetyllactosamine for maturation of immune responses in neonates |
| 12/08/2010 | CN101909635A Novel vaccines against multiple subtypes of dengue virus |
| 12/08/2010 | CN101909634A Compositions and methods for treating diseases of the nail |
| 12/08/2010 | CN101909633A Use of a gamma-secretase inhibitor for treating cancer |
| 12/08/2010 | CN101909632A Compositions comprising unsaturated fatty acids and nitric oxide releasing compounds and use thereof for enhancing congnitive and related functions |
| 12/08/2010 | CN101909631A Process for making thienopyrimidine compounds |
| 12/08/2010 | CN101909630A Methods and compounds for preventing and treating a tumour |
| 12/08/2010 | CN101909629A Crystalline (R)-2-(4-cyclopropanesulphonyl-phenyl)-N-pyrazin-2-yl-3-(tetrahydropyran-4-yl)-propionamide |
| 12/08/2010 | CN101909628A Aryl-substituted bridged or fused diamines as modulators of leukotriene A4 hydrolase |
| 12/08/2010 | CN101909627A New therapeutic uses of dual molecules containing a peroxide derivative |
| 12/08/2010 | CN101909626A Combination therapy |
| 12/08/2010 | CN101909625A Novel antiretroviral combination |
| 12/08/2010 | CN101909624A Treatment of colon diseases or prevention of colorectal carcinoma with imidazoquinoline derivatives |
| 12/08/2010 | CN101909623A Compositions and methods for treating cystic fibrosis |
| 12/08/2010 | CN101909622A Pyrrolo [1,2-C] imidazole derivates for use in the prophylaxis or treatment of cancer which is refractory to known cancer therapies |
| 12/08/2010 | CN101909621A 4-[4-(2-adamantylcarbamoyl)-5-tert-butyl-pyrazol-1-yl]benzoic acid - 465 |
| 12/08/2010 | CN101909620A Compositions and methods for treating cancer |
| 12/08/2010 | CN101909619A Composition comprising sesamin component and quercetin glycoside |
| 12/08/2010 | CN101909618A Compositions containing flavanoid polyphenol derivatives, and applications thereof in controlling diseases and ageing of living organisms |
| 12/08/2010 | CN101909617A Pharmaceutical composition for treatment and prevention of kidney diseases |
| 12/08/2010 | CN101909616A Mixture of citric flavonoids to improve ruminal fermentation |
| 12/08/2010 | CN101909615A Prevention and treatment of secondary infections following viral infection |
| 12/08/2010 | CN101909614A Nanodispersion |
| 12/08/2010 | CN101909613A Methods of using (+)-1,4-dihydro-7-[(3S,4S)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid in combination therapy |
| 12/08/2010 | CN101909612A Treatment of heart disease using beta-blockers |
| 12/08/2010 | CN101909611A Compositions and methods for enhancing immune response |
| 12/08/2010 | CN101909610A Composition for oral administration |
| 12/08/2010 | CN101909609A Use of immunomodulatory compounds for the treatment of disorders associated with endothelial dysfunction |
| 12/08/2010 | CN101909608A A slow-release formulation based on an association of glycogen and alginate |
| 12/08/2010 | CN101909604A Method of treating dysglycemia and glucose excursions |
| 12/08/2010 | CN101909602A Oral powder and granular antitumor agent |
| 12/08/2010 | CN101909601A Method to enhance aqueous solubility of poorly soluble actives using methoxypolyethylene glycol |
| 12/08/2010 | CN101909600A Fast release solid formulation, preparation and use thereof |
| 12/08/2010 | CN101909592A External preparation for skin |
| 12/08/2010 | CN101909591A Emulsion preparation for external application to skin and cosmetic |
| 12/08/2010 | CN101909590A Preparation for external application to skin and cosmetic preparation |
| 12/08/2010 | CN101909586A External skin preparation for pimpled skin |
| 12/08/2010 | CN101909462A 5-[1'-(decahydro-7-hydroxy-1,1,3A,7-tetramethyl-1H-cyclopropa[a]naphtalen-4-yl)-3'-methylbutyl]-2,4,6-trihydroxy-1,3-benzenedicarboxaldehyde used as drugs |
| 12/08/2010 | CN101909450A Solvent systems for pour-on formulations for combating parasites |
| 12/08/2010 | CN101909446A Quinoxaline-containing compounds as hepatitis c virus inhibitors |
| 12/08/2010 | CN101909441A Tubulysins and processes for preparing |
| 12/08/2010 | CN101909440A Therapeutic compounds and their use in treating diseases and disorders |
| 12/08/2010 | CN101909439A Method of aralkylation of 4'-hydroxyl group of anthracyclins |
| 12/08/2010 | CN101909438A Rasagiline formulations, their preparation and use |
| 12/08/2010 | CN101906128A Estrone compound, as well as preparation method and application thereof |
| 12/08/2010 | CN101906125A 4''-benzimidazole-5-formacyl-ester carbazate clarithomycin derivative and midbody |
| 12/08/2010 | CN101906123A 4''-aralkyl carbamic acid ester clarithomycin derivative and preparation method and application thereof |
| 12/08/2010 | CN101906122A Method for extracting rhoifolin and prepared medicament application thereof |
| 12/08/2010 | CN101906121A Bacteriostatic component extracted from ageratum conyzoides and extraction method thereof |
| 12/08/2010 | CN101906119A Novel method for preparing tenofovir |
| 12/08/2010 | CN101906106A Novel heterocyclic compounds as HSP90-inhibitors |
| 12/08/2010 | CN101906105A Pyrazolo (1,5-a) pyrimidone derivative as well as drug combination thereof and application thereof |
| 12/08/2010 | CN101906104A 2-(pyridin-2-ylamino)-pyrido[2,3-d]pyrimidin-7-ones |
| 12/08/2010 | CN101906102A Beta-carboline alkaloid derivative, preparation method and application thereof |
| 12/08/2010 | CN101906101A Rotundine crystal B-type solid matter and preparation method as well as applications |
| 12/08/2010 | CN101906100A Rotundine crystalline C-type solid substance and preparation method as well as application |
| 12/08/2010 | CN101906097A 1,3-dioxane compounds as well as synthesizing method and medical application thereof |
| 12/08/2010 | CN101906094A Preparation and application of novel antibacterial and anticancer compound and derivative thereof |
| 12/08/2010 | CN101906093A Benzo five-membered unsaturated heterocycle compound and preparation method thereof |
| 12/08/2010 | CN101906090A 3,4-dihydro-4-aryl coumarin compounds as well as preparation method and application thereof |
| 12/08/2010 | CN101906085A Compound and composition for treating cardiovascular and cerebrovascular diseases and preparation method and use thereof |
| 12/08/2010 | CN101906076A Naphthaline amide derivative serving as protein kinase inhibitor and histone deacetylase inhibitor and preparation method and application thereof |
| 12/08/2010 | CN101906072A 3-phenylquinoline compounds as well as preparation method and application thereof |
| 12/08/2010 | CN101906071A Dioxane-2-alkyl carbamates derivatives |
| 12/08/2010 | CN101906069A (S)-2-substituted-(3'-acetyl-2'-pyridone-1'-yl) acetic acid as well as preparation method and application thereof |
| 12/08/2010 | CN101906064A Preparation method of ST-246 stereoisomer |
| 12/08/2010 | CN101906056A Cycloalkane amine compound as M2 inhibitor and application thereof |
| 12/08/2010 | CN101906054A N-(3,4-dyhydroxy benzoyl)-3,4-dyhydroxy benzamide and preparation method and application thereof |
| 12/08/2010 | CN101906039A Hydroxyl acid ester compound of substituted phenol, preparation method and application in drug |
| 12/08/2010 | CN101906029A Flavonoid derivative , preparation method thereof and use thereof |
| 12/08/2010 | CN101906006A Method for efficiently synthesizing cis-stilbene derivative and phosphate disodium salt predrug thereof |
| 12/08/2010 | CN101905033A Medicament microcapsule composite calcium deficiency calcium phosphate bone cement and use, preparation method and application thereof |
| 12/08/2010 | CN101905027A Oral pharmaceutical composition containing mitiglinide calcium and cyclodextrin |
| 12/08/2010 | CN101905025A Preparation method for protective agent of intestinal mucosal barrier |
| 12/08/2010 | CN101905023A Method of effectively using medicine and method concerning prevention of side effect |
| 12/08/2010 | CN101905015A Medicine capable of decomposing alcohol, preventing drunkenness and protecting liver |